Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPXL
4401
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.52M | ﹤0.01% |
74,900
-15,800
| -17% | -$302K |
|
4402
Integra LifeSciences
IART
$1.31B
| $1.52M | ﹤0.01% |
30,101
-13,465
| -31% | -$692K |
|
4403
CALL
IDEX
IEX
$17B
| $1.52M | ﹤0.01% |
12,500
+600
| +5% | +$70.1K |
|
4404
Center Bancorp
CNOB
$1.6B
| $1.52M | ﹤0.01% |
61,680
+27,279
| +79% | +$620K |
|
4405
Spire
SR
$4.88B
| $1.52M | ﹤0.01% |
20,323
-11,328
| -36% | -$840K |
|
|
MBFI
4406
CALL
DELISTED
MB Financial Corp
MBFI
| $1.52M | ﹤0.01% |
33,700
-13,500
| -29% | -$559K |
|
4407
iShares Global Utilities ETF
JXI
$302M
| $1.52M | ﹤0.01% |
29,916
+21,375
| +250% | +$1.09M |
|
4408
CALL
Lindsay Corp
LNN
$1.16B
| $1.52M | ﹤0.01% |
16,500
+9,400
| +132% | +$838K |
|
4409
WSFS Financial
WSFS
$4B
| $1.52M | ﹤0.01% |
31,094
-20,452
| -40% | -$923K |
|
4410
CALL
Genesis Energy
GEL
$1.96B
| $1.51M | ﹤0.01% |
57,500
-45,600
| -44% | -$1.29M |
|
|
BBT
4411
Beacon Financial Corp
BBT
$2.63B
| $1.51M | ﹤0.01% |
39,083
-32,976
| -46% | -$1.16M |
|
4412
WisdomTree Enhanced Commodity Strategy Fund
GCC
$297M
| $1.51M | ﹤0.01% |
80,790
-53,604
| -40% | -$1.01M |
|
|
IPG
4413
PUT
DELISTED
Interpublic Group of Companies
IPG
| $1.51M | ﹤0.01% |
72,800
+56,400
| +344% | +$1.23M |
|
|
SONC
4414
CALL
DELISTED
Sonic Corp
SONC
| $1.51M | ﹤0.01% |
59,400
-66,900
| -53% | -$1.63M |
|
|
AMED
4415
PUT
DELISTED
Amedisys
AMED
| $1.51M | ﹤0.01% |
27,000
-37,400
| -58% | -$1.98M |
|
|
GHL
4416
PUT
DELISTED
Greenhill & Co., Inc.
GHL
| $1.51M | ﹤0.01% |
91,000
+56,900
| +167% | +$962K |
|
|
IBDN
4417
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $1.51M | ﹤0.01% |
59,831
+47,538
| +387% | +$1.2M |
|
|
GWR
4418
PUT
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.51M | ﹤0.01% |
20,400
-15,300
| -43% | -$1.05M |
|
|
IBDD
4419
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
| $1.51M | ﹤0.01% |
+56,377
| New | +$1.51M |
|
4420
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.6B
| $1.51M | ﹤0.01% |
71,900
+60,440
| +527% | +$1.24M |
|
4421
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.99B
| $1.51M | ﹤0.01% |
30,565
+722
| +2% | +$35.6K |
|
4422
CALL
Eversource Energy
ES
$26.7B
| $1.5M | ﹤0.01% |
24,900
+11,800
| +90% | +$728K |
|
|
TSC
4423
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.5M | ﹤0.01% |
65,700
-19,219
| -23% | -$432K |
|
4424
Assembly Biosciences
ASMB
$694M
| $1.5M | ﹤0.01% |
3,590
-5,570
| -61% | -$1.71M |
|
4425
Cornerstone Strategic Value Fund
CLM
$2.07B
| $1.5M | ﹤0.01% |
+103,101
| New | +$1.5M |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.